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Development Of Novel Co-Processed Excipients By Spray
Drying Method For The Design Of Fast Dissolving Tablets
S B Shirsand*, Sunil Aute, Shailashri, Raghunandan Deshpande and Amruta
Email: shirsand@rediffmail.com

Abstract
Co-processed excipients were developed by the spray drying method. In this method, MCC : Aerosil : Fenugreek
seed mucilage in different ratios (88:2:10, 90:2:8 and 92:2:6) were used. The prepared excipients were evaluated
for compressibility index, that is Carr’s index, Hausner’s ratio, and flow properties, which is the angle of repose
in comparison with physical mixture of the excipients. The angle of repose of co-processed excipients was
found to be <30o, which describes a good flow in comparison to the physical mixture of the excipients, due to
micronization, a very regular particle size is achieved. Carr’s index was found to be in the range of 11.00-13.80%
and Hausner’s ratio was found to be in the range of 1.00-1.16. Fast dissolving tablets of Repaglinide were
prepared using the above novel co- processed excipients and evaluated for pre-compression and post-compression
parametres. Among the tablets prepared, the novel co-processed formulations MCC : Aerosil : Fenugreek seed
mucilage in 88:2:10 ratio was found to be promising and showed a dispersion time of approximately 37.66
seconds. The wetting time was found to be 35.66 seconds, which facilitated its faster dispersion in the mouth.
Stability studies of promising formulations indicated that there were no significant changes in the drug content
and in vitro dispersion time. IR-spectroscopic studies indicated that there were no drug-excipient interactions.
It can be concluded from the present work that novel co-processed excipients used in repaglinide fast dissolving
tablets were found to be superior in flow characteristics in comparison with the physical mixture of the same
excipients.
Key words: Aerosil, Co-processed Excipients, Fenugreek Seed Mucilage, Microcrystalline cellulose, Repaglinide,
Spray drying

Introduction
The major challenge for tablets and capsule
manufacturing comes from the flow properties
of the materials to be compressed. Most of the
formulations (>70%) contain excipients at a higher
concentration than active drug.[1] In the recent
years, drug formulation scientists have identified
that single-component excipients cannot always
provide the requisite performance to allow certain
active pharmaceutical ingredients to be formulated
or manufactured adequately.[2] Hence, there
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is a necessity to have excipients with multiple
characteristics built into them such as better flow,
no moisture sensitivity, greater compressibility and
rapid disintegration ability.[3] One such approach for
improving the functionality of excipients is the coprocessing of two or more excipients.
Co-processing is based on the novel concept of two
or more excipients interacting at the sub-particle
level. The main objective of this is to provide a
synergy of functionality improvement as well as
masking the undesirable properties of individual
excipients.[4] Co-processing excipients leads to the
formulation of excipient granules with superior
properties compared to the physical mixtures of
components or individual components.[5] The
concept of formulating fast dissolving tablets (FDT)
of repaglinide (antidiabetic) using co-processed
excipients, which increased the water uptake with
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Table 1: Formulations of Repaglinide Fast Dissolving Tablets
Formulation Code
MCAF1
MCAF2
1
1
12
12
3
3
1.5
1.5

Ingredients (mg/tablet)
Repaglinide
Co-processed Excipients
Aspartame
Sodium stearyl fumarate

CP0
1
3
1.5

Talc

3

3

3

3

Pine apple Flavour
MCC (Avicel PH-102)
Mannitol (Pearlitol SD 200)
Total Weight

1.5
30
110
150

1.5
30
98
150

1.5
30
98
150

1.5
30
98
150

MCAF3
1
12
3
1.5

CPo-Control formulation (without Co-processed excipients).
MCAF Indicates: Microcrystalline cellulose, Aerosil & Fenugreek seed mucilage.

shortest wetting time and thereby decreased the
disintegration time of the tablets by simple and cost
effective (at low concentration of excipients) direct
compression technique. [6-8]
Materials
Repaglinide was gifted from Torrent Pharmaceuticals,
Sikkim Plant. Aerosil was gifted from Alkem Labs
Pvt Ltd, Mumbai, India. Fenugreek powder was
prepared in HKEs college laboratory. All the other
chemicals used were of analytical grade.
Development of Co-Processed Excipients9
Development of Co-processed Excipients by
Spray Drying Method:
Procedure:
Co-processed excipients were prepared by using
spray-drying technique using a laboratory spray dryer
(Model SPD-P-111; Technosearch Instruments,
India) with a standard 0.7 mm nozzle. Different
batches of co-processed excipients were prepared
by dissolving the different ratios of polymer MCC :
Aerosil : Fenugreek seed mucilage in different ratios
(88:2:10, 90:2:8 and 92:2:6) in Dimethylformamide
(DMF) under constant stirring at 500 rpm for 2
hours using a magnetic stirrer. When the polymer
Dimethylformamide (DMF) solution was fed to
the nozzle with a peristaltic pump, the atomization
occurred by the force of compressed air, disrupting
the Dimethylformamide (DMF) solution into little
droplets. The droplets, together with hot air, were
blown into the drying chamber, where the solvent in
the droplets was evaporated and discharged through

an exhaust tube. The co-processed excipients were
collected from cyclone one and cyclone two, washed
with distilled to remove surface adhered excipients
and further dried completely in hot air oven at 40°C
for 12 hours and stored in a well-closed container.
The processing conditions of the spray drying were:
Inlet Temperature: 165°C
Outlet temperature: 120°C
Feed pump rate: 2ml/min
Spray pressure atomization: 2×105 PC.
Isolation of Mucilage By conventional method10:
Seeds were collected and soaked in distilled water
for forty eight hours and then boiled for one hour for
the complete release of mucilage into the water. The
material was then filtered by squeezing it in a muslin
cloth to remove marc. An equal volume of acetone
was added to the filtrate to precipitate the formed
mucilage. The mucilage was collected separately
and dried in an oven at temperature less than 600C,
powdered (# 60) mesh, weighed and stored in an
airtight well-closed container until further use.
Preparation of fast dissolving tablets of
Repaglinide by direct compression method:
Fast dissolving tablets of Repaglinide were directly
compressed according to the formulae given in Table
1. All the ingredients were sifted through 60 mesh
separately. The drug and Microcrystallinecellulose
were mixed by a little portion of both each time and
blending it to get a uniform mixture and kept aside.
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Then, the ingredients were weighed and mixed in a
geometrical order and the tablets were compressed
at 7 mm size to get a tablet of 150 mg weight using
a Rotary Clit 10 station compression machine. [11]
Evaluation of Physically mixed Excipients/Coprocessed Excipients:
The developed excipients were evaluated for
compressibility index (Carr’s index), Hausner’s ratio
and flow properties (angle of repose) in comparison
with physical mixture of excipients shown in Table
2.
Evaluation of fast dissolving tablets:
The prepared batches of formulations were
evaluated post compression parametres such as
drug content uniformity, weight variation, hardness,
friability, thickness, in vitro dispersion time, in vitro
drug release and stability studies (given in Table 3).
Weight Variation:
The weight of the prepared tablet was routinely
determined to ensure that a tablet contains the
proper quantity of the drug. The USP weight
variation test is done by collecting 20 tablets at
random and weighing them individually, and the
individual weights were compared with that of the
average weight for the determination of weight
variation.[12]
Thickness variation:
The thickness of the tablet is important for the
uniformity of tablet size. The thickness was
measured using Vernier Calipers. It was determined
by measuring the thickness of three tablets of each
formulation.
Tablet Hardness and Friability:
The resistance of tablets to shipping or breakage
under conditions of storage, transportation and
handling before usage is dependent on its hardness.
The hardness of each batch of tablet was checked
by using monsanto hardness tester. The hardness
was measured in terms of kg/cm2. Three tablets
were chosen randomly and tested for hardness. The
average hardness of three tablets was recorded.
Friability generally refers to loss in weight of tablets
in the containers due to removal of fines from the
surface of tablets. Friability generally reflects poor
34
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cohesion of tablet ingredients. Ten tablets were
weighed and the initial weight of these tablets was
recorded and placed in Roche friabilator and rotated
at the speed of 25 rpm for 100 revolutions. Then the
tablets were removed from the friabilator, dusted off
of the fines and again weighed, and the weight was
recorded.
Drug Content Uniformity:
Ten tablets were weighed and powdered, the quantity
of powder equivalent to 1 mg of Repaglinide was
transferred to a 50 ml volumetric flask and 40 ml
methanol was added to the flask. The drug was
extracted into the methanol by shaking the flask
vigorously for 15 minutes. Then the volume was
adjusted to 50 ml with methanol and the liquid was
filtered. The Repaglinide content was determined
by measuring the absorbance at 237 nm after an
appropriate dilution with methanol. The drug content
was calculated using the standard calibration curve.
The mean percent drug content was calculated as an
average of three determinations.[13]
Wetting Time and Water Absorption Ratio:
A piece of tissue paper folded twice was placed
in a small petri dish containing 6 ml of water. A
tablet was put on the paper and the time required
for complete the wetting was measured. The wetted
tablet was then weighed (given in Table 3).[14]
Water absorption ratio ‘R’ was determined using the
following equation:

Where,
Wa = Tablet weight before water absorption,
Wb = tablet weight after water absorption.
In vitro Dispersion Time:
The tablet was added to 10 ml of phosphate buffer
solution in a beaker, pH 6.8 at 37±0.5°C. Time
required for complete dispersion of the tablet was
measured (given in Table 3).[15]
In vitro Dissolution Study:
In vitro dissolution of a Repaglinide FDT was
studied in USP type-II dissolution apparatus
(Electrolab) employing a paddle stirrer. 900 ml of
phosphate buffer pH 6.8 was used as a dissolution
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Table 2: Pre-compression Parameters of physically mixed excipients/Co-processed Excipients
Formulation Code
Parameters

PMCAF1

MCAF1

PMCAF2

MCAF2

PMCAF3

MCAF3

Bulk density (g/cc)

0.45

0.50

0.45

0.51

0.45

0.51

Tapped density (g/cc)

0.55

0.57

0.55

0.58

0.53

0.60

Angle of repose (degree)°

27.75

23.91

28.39

24.00

28.65

24.17

Carr’s index (%)

18.21

11.96

18.91

12.10

18.72

13.80

Hausner’s Ratio

1.22

01.13

1.22

01.14

1.23

01.16

Percent drug
content (%)*
±SD

Weight
variation
(%)

99.45±0.01
99.35±0.79
99.28±2.02
99.35±1.57

142-158 mg
(IP limits ±
7.5%)

Table 3: Post-compression Parameters of Repaglinide Fast Dissolving Tablet formulations.
Parameters→
Hardness
Friability Thickness*
Formulation
(kg/cm2)*
(%)
(mm
Code
±SD
↓
CPO
2.5±0.10
0.33
2.60±0.17
MCAF1
2.55±0.05
0.63
2.43±0.15
MCAF2
2.61±0.70
0.67
2.60±0.17
MCAF3
2.56±0.07
0.67
2.76±0.15

In vitro
dispersion
time (s)*
±SD
122±4.35
37.66±1.52
43.00±3.05
44.66±4.16

Wetting
time (s)* ±
SD
115±2.00
35.66±1.53
41.00±4.35
39.66±2.08

Water
absorption
ratio (%)*
±SD
56.86±1.40
85.63±0.60
83.67±1.40
80.95±2.05

*Average of three determinations
Table 4: Comparative in vitro Dissolution parameters of control, commercial and promising formulations in pH 6.8 Phosphate
Buffer
parameters
CP0
MCAF1
CCF

D5

D10

D15

t50%

t70%

t90%

DE10min

27%
55%
26%

50%
84%
50%

57%
91%
56%

10 min
4.2 min
10 min

>30 min
7.6 min
>30 min

>30 min
14 min
>30 min

26.69%
53.03%
25.21%

CP0 is control formulation, MCAF1 is promising fast dissolving tablet formulation, CCF is conventional commercial tablet
formulation, D5 is percent drug released in 5 minutes, D10 is percent drug release in 10 minutes, D15 is percent drug release in
15 minutes, DE10 min is dissolution efficiency at 10 minutes, t50% is time for 50% drug dissolution, t70% is time for 70% drug
dissolution, t90% is time for 90% drug dissolution.

medium. The stirrer was adjusted to rotate at 50
rpm. The dissolution media was previously warmed
to 37±0.5ºC and was maintained same throughout
the experiment. One tablet was used in each test.
5 ml of the sample of dissolution medium were
withdrawn by means of a syringe fitted with prefilter at known intervals of time and analyzed for
drug release by measuring the absorbance at 241 nm.
The volume withdrawn at each time interval was
replaced with fresh quantity of dissolution medium.
Percentage amount of Repaglinide released was
calculated and plotted against time. For comparison,
the dissolution of Repaglinide from commercial
formulation was also studied.

coloured screw capped bottle at an elevated
temperature of 40ºC/ 75% RH over a period of
three months. At an interval of 1 month, the tablets
were visually examined for any physical changes,
changes in drug content and in vitro dispersion time.

Accelerated Stability Studies:
Promising formulation stability studies (MCAF1)
was carried out by storing 15 tablets in an amber

Figure 1: Comparative cumulative percent drug release versus
time plot (zero order) of control formulation, promising tablet
formulations of Repaglinide and Commercial Conventional
Formulation CCF in phosphate buffer pH 6.8
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CCF............. Commercial conventional formulation
FDT............. Fast dissolving tablet
MCC........... Microcrystalline cellulose
min.............. Minutes
rpm.............. Revolutions per minute
s................... Seconds
SD............... Standard deviation

Results and Discussion
Co-processed excipients were prepared by spray
drying using co-processed excipients MCC : Aerosil :
Fenugreek seed mucilage in different ratios (88:2:10,
90:2:8 and 92:2:6). The co-processed excipients were
evaluated for their flow and compression properties
in comparison with physical mixture of excipients.
The angle of repose of co-processed excipients was
found to be <30o, which indicated an excellent flow
in comparison to the physical mixture of excipients
(near to 30o) due to granule formation, Carr’s index
in the range of 11.00-13.80% and Hausner’s ratio in
the range of 1.00-1.16 (Table 2).
Fast dissolving tablets of Repaglinide were prepared
using above co-processed excipients. A total of
three formulations and the control formulation
CP0 (without excipients) were developed. As the
blends were free flowing (angle of repose <30 and
Carr’s index <15 % Table 2), tablets obtained were
of uniform weight (due to uniform die fill), with
acceptable variations as per IP specification i.e.,
below 7.5%. The drug content was found to be in the
range of 99.28 to 99.35%, which is within acceptable
limits. The hardness of the tablets was found to
be in the range of 2.55-2.61 kg/cm2. Friability
below 1% was an indication of good mechanical
resistance of the tablets. Water absorption ratio
and wetting time, which are important criteria for
understanding the capacity of excipients to swell
in presence of little amount of water, were found
to be in the range of 80.95-85.63% and 35.66-41.00
seconds, respectively. Among the tablets prepared,
co-processed formulations MCAF1 containing MCC
: Aerosil : Fenugreek seed mucilage in different
ratios (88:2:10) were found to be promising and
showed an in-vitro dispersion time of 37.66
seconds, wetting time of 35.66 seconds, and water
absorption ratio of 85.63% and control formulation
(CP0) showed 122 seconds, 115 seconds, and 56.86%
values, respectively for the above parametres (Table
36
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3). In-vitro dissolution studies on the promising
formulation MCAF1, control (CP0) and commercial
conventional formulations (CCF) were carried out in
pH 6.8 phosphate buffer, and the various dissolution
parametre values viz., percent drug dissolved in 5,
10 and 15 minutes (D5, D10 and D15), dissolution
efficiency at 10 minutes (DE10 min), t50%, t70% and
t90% are shown in Table 4 and the dissolution profile
depicted in Figure 1. This data reveals that overall,
the formulation MCAF1 has shown about nearly two
and a half fold faster drug release when compared
to the commercial conventional tablet formulation
of Repaglinide (t50% in 4.20 min). IR spectroscopic
studies indicated that the drug is compatible with all
the excipients. The IR spectrum of MCAF1 showed
all the characteristic peaks of Repaglinide pure
drug, thus confirming that no interaction of drug
occurred with the components of the formulation.
Stability studies of the above formulations indicated
that there are no significant changes in the drug
content and in vitro dispersion time at the end of the
three-month period (p<0.05).
Conclusion
Repaglinide tablets containing co-processed
excipients exhibited good flow and compression
characteristics. Repaglinide tablets containing coprocessed excipients exhibited quick disintegration
and improved drug dissolution. It can be concluded
from the present work that co-processed excipients
of MCC, Aerosil and Fenugreek seed mucilage
are superior to physical mixture of MCC, Aerosil
and Fenugreek seed mucilage. The developed coprocessed excipients may be used in future research
for the development of novel solid dosage forms.
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